Future Financial Wealth Management’s abrdn Life Sciences Investors HQL Stock Holding History

Future Financial Wealth Management’s Portfolio HQL Stock Details HQL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-2,000	Closed	-$31K	–	247
2025 Q3	$31K	Hold	2,000	–	–	0.02%	304
2025 Q2	$25.6K	Hold	2,000	–	–	0.02%	304
2025 Q1	$25.4K	Hold	2,000	–	–	0.02%	300
2024 Q4	$26.2K	Hold	2,000	–	–	0.02%	297
2024 Q3	$30.2K	Buy	+2,000	New	+$30.3K	0.02%	298
2024 Q2	–	Sell	-2,000	Closed	-$27.3K	–	254
2024 Q1	$27.3K	Buy	+2,000	New	+$27.7K	0.02%	319
2022 Q2	–	Sell	-2,000	Closed	-$33K	–	269
2022 Q1	$33K	Hold	2,000	–	–	0.03%	317
2021 Q4	$39K	Buy	+2,000	New	+$40.2K	0.03%	305

Other funds holding HQL

SCM

Saba Capital Management New York $3.62B AUM 13% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

PCM

Penserra Capital Management Orinda, California $8.52B AUM 37.76% 1-Year Est. Return

Raymond James Financial St Petersburg, Florida $324B AUM 22.36% 1-Year Est. Return

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

NIM

Needham Investment Management New York $1.96B AUM 101.23% 1-Year Est. Return

FHA

Flagship Harbor Advisors Boston, Massachusetts $2.27B AUM 18.34% 1-Year Est. Return

Allspring Global Investments Charlotte, North Carolina $59.7B AUM 29.08% 1-Year Est. Return

RCM

Rivernorth Capital Management West Palm Beach, Florida $2B AUM 0.66% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Future Financial Wealth Management's HQL Position: Q4 2025 in Review

Future Financial Wealth Management sold out of abrdn Life Sciences Investors (HQL) in Q4 2025, closing a stake of 2,000 shares — an estimated $31K sold.

Future Financial Wealth Management first reported a position in HQL in Q4 2021 and held it in 8 quarters. The position peaked at $39K in Q4 2021. 73 funds tracked by Wall St. Rank hold HQL as of Q4 2025.

Future Financial Wealth Management reported no remaining abrdn Life Sciences Investors position as of Q4 2025 after selling out during the quarter.
Future Financial Wealth Management sold 2,000 abrdn Life Sciences Investors shares in Q4 2025, an estimated $31K.
Future Financial Wealth Management first reported a position in abrdn Life Sciences Investors in Q4 2021 and held it in 8 quarters.
Future Financial Wealth Management's abrdn Life Sciences Investors position peaked at $39K in Q4 2021.
73 funds tracked by Wall St. Rank held abrdn Life Sciences Investors as of Q4 2025.

Based on Future Financial Wealth Management's 13F filing for Q4 2025, filed 21 Jan 2026.